Heparin-bonded, Expanded Polytetrafluoroethylene-lined Stent Graft in the Treatment of Femoropopliteal Artery Disease: 1-Year Results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) Trial

2013 ◽  
Vol 24 (2) ◽  
pp. 165-173 ◽  
Author(s):  
Richard R. Saxon ◽  
Arun Chervu ◽  
Paul A. Jones ◽  
Tanvir K. Bajwa ◽  
Dennis R. Gable ◽  
...  
Keyword(s):  
Stent Graft ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Femoropopliteal Artery ◽  
Expanded Polytetrafluoroethylene ◽  
Obstructive Disease ◽  
Artery Disease

scholarly journals “Low Echoic Area” around stent after bare and drug-coated stenting or stent graft placement for superficial femoral artery disease

2021 ◽  
Vol 9 ◽  
pp. 2050313X2110145
Author(s):  
Yoshimitsu Soga ◽  
Kenji Ando
Keyword(s):  
Stent Graft ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
Cook Medical ◽  
Artery Disease ◽  
Zilver Ptx ◽  
Cordis Corporation

Restenosis after stent implantation in femoropopliteal lesions is still big issue. However, restenosis has been reduced by the recent new drug-eluting stent “Eluvia” (Boston Scientific, Marlborough, MA, USA). However, it was reported that “low echoic area (LEA)” finding around stent by ultrasound that they called “aneurysmal degeneration,” but no blood flow was identified outside the stent was confirmed after Eluvia implantation. In this report, we describe the similar findings that were observed after other types of stents (S.M.A.R.T. bare-nitinol stent (Cordis Corporation, Hialeah, FL, USA), Zilver PTX drug-coated stent (Cook Medical, Bloomington, IN, USA), and Viabahn stent graft (W. L. Gore & Associates, Newark, Delaware, USA)) for superficial femoral artery disease. These findings did not change to “aneurysmal change” during the follow-up.

Is There an Alternative to the Surgical Above-Knee Bypass in Treatment of Superficial Femoral Artery Disease? Experiences With Viabahn Stent Graft

2013 ◽  
Vol 47 (7) ◽  
pp. 502-506 ◽  
Author(s):  
A. Fawad Jebran ◽  
Aron F. Popov ◽  
Dieter Zenker ◽  
Christian Bireta ◽  
Martin Friedrich ◽  
...  
Keyword(s):  
Stent Graft ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Artery Disease

scholarly journals Twisting of the Ranger Drug-Coated Balloon for Treating Superficial Femoral Artery Disease

2021 ◽  
Author(s):  
Su Hong Kim ◽  
Jong Hyun Choi ◽  
Bo Won Kim ◽  
Sang Hee Kim
Keyword(s):  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Percutaneous Transluminal Angioplasty ◽  
Transluminal Angioplasty ◽  
Femoropopliteal Artery ◽  
Artery Disease ◽  
Percutaneous Transluminal ◽  
Drug Coated Balloon

Paclitaxel-coated balloons have demonstrated improved efficacy compared with uncoated percutaneous transluminal angioplasty for femoropopliteal artery disease. While applying a long balloon, twisting of the balloon can be occurred. We reported two cases with twisting of the Ranger drug-coated balloon for treating superficial femoral artery.

scholarly journals Viabahn stent graft compared with prosthetic surgical above-knee bypass in treatment of superficial femoral artery disease

Medicine ◽  
2018 ◽  
Vol 97 (40) ◽  
pp. e12449
Author(s):  
Narges Waezi ◽  
Shekhar Saha ◽  
Ioannis Bougioukas ◽  
Alexander Emmert ◽  
Bernhard Christoph Danner ◽  
...  
Keyword(s):  
Stent Graft ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Artery Disease

Histological Evaluation of a Self-Expanding Stent-Graft 23 Months After Implantation in the Superficial Femoral Artery

2017 ◽  
Vol 24 (5) ◽  
pp. 746-750 ◽  
Author(s):  
Takayuki Ishihara ◽  
Osamu Iida ◽  
Katsumi Inoue ◽  
Masashi Fujita ◽  
Masaharu Masuda ◽  
...  
Keyword(s):  
Stent Graft ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Giant Cells ◽  
Middle Part ◽  
Histological Evaluation ◽  
Artery Disease ◽  
The Right ◽  
Stent Graft Implantation ◽  
Graft Implantation

Purpose: To report histological examination of a Viabahn stent-graft implanted in the superficial femoral artery (SFA) for nearly 2 years. Case Report: A 78-year-old man with peripheral artery disease was treated successfully with a 6.0×250-mm Viabahn self-expanding stent-graft in the right SFA, relieving his lower limb claudication. The patient died suddenly due to acute myocardial infarction 23 months later. Histological evaluation of the stent-graft implantation site revealed moderate neointimal proliferation at both proximal and distal edges of the device. In the middle part of the stent, significant macrophages and multinucleated foreign body giant cells had accumulated, although the stent was entirely patent. Furthermore, no endothelial cell coverage was found. Conclusion: Judging from these features, it might be necessary to continue dual antiplatelet therapy after stent-graft implantation over the long term to prevent thrombosis and subsequent restenosis or reocclusion.

scholarly journals One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study)

2016 ◽  
Vol 63 (2) ◽  
pp. 370-376.e1 ◽  
Author(s):  
Takao Ohki ◽  
John F. Angle ◽  
Hiroyoshi Yokoi ◽  
Michael R. Jaff ◽  
Jeffrey Popma ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Artery Disease ◽  
One Year ◽  
The U.S

scholarly journals Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging

2020 ◽  
Vol 8 ◽  
pp. 2050313X2090782
Author(s):  
Norihiro Kobayashi ◽  
Keisuke Hirano ◽  
Masahiro Yamawaki ◽  
Motoharu Araki ◽  
Tsuyoshi Sakai ◽  
...  
Keyword(s):  
Frequency Domain ◽  
Femoral Artery ◽  
Balloon Angioplasty ◽  
Superficial Femoral Artery ◽  
Optical Frequency ◽  
Optical Frequency Domain Imaging ◽  
Drug Retention ◽  
Artery Disease ◽  
The Right

A 63 year-old woman with claudication underwent endovascular therapy for diffuse stenosis of the right superficial femoral artery in our hospital. We performed paclitaxel-coated balloon angioplasty using the IN.PACT™ Admiral™ and achieved acceptable results. After 42 days, we performed follow-up optical frequency domain imaging for the right superficial femoral artery lesion treated with paclitaxel-coated balloon and observed several high-intensity regions with attenuation on the lumen surface. Sustained drug availability is a notable characteristic of paclitaxel-coated balloon. To the best of our knowledge, this is the first report on the visualization of sustained drug retention on the lumen surface using follow-up optical frequency domain imaging after paclitaxel-coated balloon angioplasty in a human patient with superficial femoral artery disease.

Sign in / Sign up

Export Citation Format

Share Document